UBS Group’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.3M | Buy |
950,764
+162,335
| +21% | +$2.27M | ﹤0.01% | 2199 |
|
|
2025
Q1 | $10.7M | Sell |
788,429
-64,432
| -8% | -$876K | ﹤0.01% | 2298 |
|
|
2024
Q4 | $17.4M | Buy |
852,861
+711,458
| +503% | +$14.5M | ﹤0.01% | 1876 |
|
|
2024
Q3 | $4.12M | Buy |
141,403
+5,180
| +4% | +$151K | ﹤0.01% | 2439 |
|
|
2024
Q2 | $3.16M | Sell |
136,223
-207,656
| -60% | -$4.82M | ﹤0.01% | 2466 |
|
|
2024
Q1 | $7.06M | Buy |
343,879
+52,894
| +18% | +$1.09M | ﹤0.01% | 1870 |
|
|
2023
Q4 | $6.24M | Buy |
290,985
+181,289
| +165% | +$3.89M | ﹤0.01% | 1808 |
|
|
2023
Q3 | $2.26M | Sell |
109,696
-22,244
| -17% | -$459K | ﹤0.01% | 2454 |
|
|
2023
Q2 | $3.89M | Buy |
131,940
+4,589
| +4% | +$135K | ﹤0.01% | 2107 |
|
|
2023
Q1 | $2.93M | Buy |
127,351
+7,170
| +6% | +$165K | ﹤0.01% | 2258 |
|
|
2022
Q4 | $3.34M | Buy |
120,181
+77,727
| +183% | +$2.16M | ﹤0.01% | 2138 |
|
|
2022
Q3 | $1.3M | Buy |
42,454
+36,079
| +566% | +$1.11M | ﹤0.01% | 2656 |
|
|
2022
Q2 | $188K | Sell |
6,375
-32,737
| -84% | -$965K | ﹤0.01% | 3998 |
|
|
2022
Q1 | $1.26M | Sell |
39,112
-53,236
| -58% | -$1.71M | ﹤0.01% | 3028 |
|
|
2021
Q4 | $4.12M | Buy |
92,348
+27,868
| +43% | +$1.24M | ﹤0.01% | 2272 |
|
|
2021
Q3 | $3.25M | Buy |
64,480
+62,043
| +2,546% | +$3.13M | ﹤0.01% | 2385 |
|
|
2021
Q2 | $191K | Sell |
2,437
-27,792
| -92% | -$2.18M | ﹤0.01% | 4362 |
|
|
2021
Q1 | $1.73M | Buy |
30,229
+24,433
| +422% | +$1.4M | ﹤0.01% | 2896 |
|
|
2020
Q4 | $485K | Sell |
5,796
-461
| -7% | -$38.6K | ﹤0.01% | 3695 |
|
|
2020
Q3 | $224K | Buy |
6,257
+3,570
| +133% | +$128K | ﹤0.01% | 3922 |
|
|
2020
Q2 | $65K | Sell |
2,687
-9,121
| -77% | -$221K | ﹤0.01% | 4821 |
|
|
2020
Q1 | $207K | Buy |
11,808
+9,500
| +412% | +$167K | ﹤0.01% | 3872 |
|
|
2019
Q4 | $40K | Sell |
2,308
-2,420
| -51% | -$41.9K | ﹤0.01% | 5422 |
|
|
2019
Q3 | $72K | Buy |
4,728
+459
| +11% | +$6.99K | ﹤0.01% | 5040 |
|
|
2019
Q2 | $89K | Buy |
4,269
+269
| +7% | +$5.61K | ﹤0.01% | 4607 |
|
|
2019
Q1 | $93K | Sell |
4,000
-74,485
| -95% | -$1.73M | ﹤0.01% | 4329 |
|
|
2018
Q4 | $1.62M | Buy |
78,485
+69,427
| +766% | +$1.43M | ﹤0.01% | 2606 |
|
|
2018
Q3 | $197K | Buy |
9,058
+14
| +0.2% | +$304 | ﹤0.01% | 4245 |
|
|
2018
Q2 | $138K | Sell |
9,044
-1,885
| -17% | -$28.8K | ﹤0.01% | 4349 |
|
|
2018
Q1 | $215K | Buy |
10,929
+10,729
| +5,365% | +$211K | ﹤0.01% | 3942 |
|
|
2017
Q4 | $3K | Buy |
+200
| New | +$3K | ﹤0.01% | 6546 |
|